No benefit from ramucirumab in first-line chemotherapy?

Lignende værker

• Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
  af: Kawai, Sadayuki, et al.
  Udgivet: (2020)
• Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy
  af: Mitani, Seiichiro, et al.
  Udgivet: (2016)
• NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
  af: Marta Schirripa, et al.
  Udgivet: (2018-01-01)
• NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients
  af: Schirripa, Marta, et al.
  Udgivet: (2018)
• First-line chemotherapy for ovarian cancer – the controversy continues
  af: Kaye, S B
  Udgivet: (2002)